Molecular biological aspects of acquired bullous diseases

Critical Reviews in Oral Biology and Medicine

Volumn 9, Issue 2, 1998, Pages 162-178

  Dabelsteen, E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bullous lesions; Bullous pemphigoid; Cicatricial pemphigoid; Pemphigus foliaceus; Pemphigus vulgaris

Indexed keywords

AUTOIMMUNITY; BULLOUS SKIN DISEASE; CELL ADHESION; CELL CONTACT; DESMOSOME; HEMIDESMOSOME; HISTOPATHOLOGY; IMMUNOPATHOLOGY; MOUTH DISEASE; MUCOUS MEMBRANE PEMPHIGOID; PATHOGENESIS; PEMPHIGOID; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REVIEW;

EID: 0031968544     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411980090020201     Document Type: Review

References (147)

1. Alberts B, Bray D, Lewis I, Raff M, Roberts K, Watson JD (1994). Molecular biology of the cell. New York, NY: Garland Publishing Inc.
2. Allen E, Yu QC, Fuchs E (1996). Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 133:1367-1382.
3. Allen EM, Giudice GJ, Diaz LA (1993). Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein. J Invest Dermatol 100:685-691.
4. Amagai M, Klaus-Kovtun V, Stanley JR (1991). Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869-877.
5. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR (1992). Autoantibodies against the amino-terminal cadherinlike binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 90:919-926.
6. Amagai M, Hashimoto T, Shimizu N, Nishikawa T (1994a). Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by Baculovirus. J Clin Invest 94:59-67.
7. Amagai M, Karpati S, Klaus-Kovtun V, Udey MC, Stanley JR (1994b). Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion (publ. erratum). J Invest Dermatol 102:402-408.
8. Amagai M, Koch PJ, Nishikawa T, Stanley JR (1996). Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 106:351-355.
9. Anhalt GJ, Morrison L (1993). Pemphigoid: bullous, gestational, and cicatricial. In: Bullous diseases. Provost TT, Weston WL, editors. St. Louis: Mosby-Year Book, Inc., pp. 63-113.
10. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA (1982). Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:11891196.
11. Anhalt GJ, Patel HP, Labib RS, Diaz LA, Proud D (1986a). Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol 136:113-117.
12. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF (1986b). Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 137:2835-2840.
13. Anhalt GJ, Kim S-C, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. (1990). Paraneoplastic pemphigus. N Engl J Med 323:1729-1735.
14. Arnemann J, Sullivan KH, Magee AI, King IA, Buxton RS (1993). Stratification-related expression of isoforms of the desmosomal cadherins in human epidermis. J Cell Sci 104:741-750.
15. Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, et al. (1996). Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106:141-146.
16. Bean SF, Rogers RS, Jordon RE, Furey NL, Michel B (1979). Cicatricial pemphigoid. In: Immunopathology of the skin. Beutner EH, Chorzelski TP, Bean SF, editors. New York: John Wiley & Sons, pp. 257-263.
17. Beutner EH, Chorzelski TP, Bean SF (1979). Immunopathology of the skin. New York: John Wiley & Sons, Inc.
18. Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR (1995). Correlation of peptide specificity and IgG subclass with pathogenic and ňonpathogenic autoantibodies in pemphigus vulgaris: A model for autoimmunity. Proc Natl Acad Sci USA 92:5239-5243.
19. Bonifas JM, Rothman AL, Epstein EH Jr (1991). Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 254:1202-1205.
20. Borradori L, Caldwell JB, Briggaman RA, Burr CE, Gammon WG, James WD, et al. (1995). Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 131:590-595.
21. Briggaman RA, Gammon WR (1993). Epidermolysis bullosa acquisita and other acquired blistering diseases manifesting autoimmunity to type VII collagen. In: Bullous disease. Provost TT, Weston WL, editors. St. Louis: Mosby Year Book, Inc., pp. 115-156.
22. Burgeson RE, Lunstrum GP, Rokosova B, Rimberg CS, Rosenbaum LM, Keene DR (1990). The structure and function of type VII collagen. Ann NY Acad Sci 580:32-43.
23. Buschard K, Dabelsteen E, Bretlau P (1981). A model for the study of autoimmune diseases applied to pemphigus: transplants of human oral mucosa to athymic nude mice binds pemphigus antibodies in vivo. J Invest Dermatol 76:171-173.
24. Buxton RS, Cowin P, Franke WW, Garrod DR, Green KJ, King IA, et al. (1993). Nomenclature of the desmosomal cadherins. J Cell Biol 121:481-483.
25. Calvanico NJ, Martins CR, Diaz LA (1991). Characterization of pemphigus foliaceus antigen from human epidermis. J Invest Dermatol 96:815-821.
26. Calvanico NJ, Swartz SJ, Diaz LA (1993). Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients. J Autoimmun 6:145-157.
27. Chan LS, Traczyk T, Taylor TB, Eramo LR, Woodley DT, Zone JJ (1995). Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol 131:1432-1437.
28. Chorzelski TP, Cormane RH (1968). The presence of complement "bound" in vivo in the skin of patients with pemphigoid. Dermatologica 137:134-138.
29. Chorzelski TP, Jablonska S, Beutner EH (1987). Bullous pemphigoid: relationship of immunopathology to clinical findings. In: Immunopathology of the skin. Beutner EH, Chorzelski TP, Kumar V, editors. New York: John Wiley & Sons, Inc., pp. 337-354.
30. Christiano AM, Uitto J (1996). Molecular complexity of the cutaneous basement membrane zone. Exp Dermatol 5:1-11.
31. Cintin C, Joffe P, Ladefoged SD, Dabelsteen E, Menn' T (1992). Pemphigus foliaceus treated successfully with plasma exchange. Int J Dermatol 31:871-972.
32. Cotterill JA, Barker DJ, Millard IG (1978). Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol 98:243.
33. Coulombe PA, Hutton NE, Vassar R, Fuchs E (1991). A function for keratin and a common thread among different types of epidermolysis bullosa simplex diseases. J Cell Biol 115:1661-1674.
34. Dabelsteen E (1978). Distribution of complement and immunoglobulin in oral pemphigus lesions. Acta Derm Venereol 58:540-542.
35. Dabelsteen E, Ulman S, Thomsen K, Rygaard J (1974). Demonstration of basement membrane autoantibodies in patients with benign mucous membrane pemphigoid. Acta Derm Venereol 54:189-192.
36. Diaz LA, Calvanico NJ, Tomasi TB, Jordon RE (1977). Bullous pemphigoid antigen: isolation from normal human skin. J Immunol 118:455-460.
37. Diaz LA, Sampaio SA, Rivitti EA, Martins CR, Cunha PR, Lombardi C, et al. (1989). Endemic pemphigus foliaceus (fogo selvagem). I. Clinical features and immunopathology. J Am Acad Dermatol 20:657-669.
38. Dmochowski M, Hashimoto T, Bhogal BS, Black MM, Miyakawa K, Miyamoto R, et al. (1993). Concomitant occurrence of circulating IgA anti-intercellular and anti-basement membrane zone antibodies in autoimmune blistering: immunofluorescence and immunoblot studies. J Dermatol 20(3):131-137.
39. Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB (1992). Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 90:1628-1633.
40. Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, et al. (1994). Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 130:1521-1529.
41. Eady RA (1994). The hemidesmosome: a target in autoimmune bullous disease. Dermatology 189:38-41.
42. Eady RA, McGrath JA, McMillan JR (1994). Ultrastructural clues to genetic disorders of skin: the dermal-epidermal junction. J Invest Dermatol 103(Suppl 5):13S-18S.
43. Emery DJ, Diaz LA, Fairley JA, Lopez A, Taylor AF, Giudice GJ (1995). Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol 104:323-328.
44. Eyre RW, Stanley JR (1988). Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 81:807-812.
45. Fine J-D, Bauer EA, Briggaman RA, Carter DM, Eady RAJ, Esterly NB, et al. (1991). Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. J Am Acad Dermatol 24:119-135.
46. Fuchs E, Coulombe P, Cheng J, Chan YM, Hutton E, Syder A, et al. (1994). Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis. J Invest Dermatol 103(Suppl 5):25S-30S.
47. Gammon WR (1987). The immunopathology of bullous pemphigoid antibodies. In: Immunopathology of the skin. Beutner EH, Chorzelski TP, Kumar V, editors. New York: John Wiley & Sons, Inc., pp. 323-336.
48. Gammon WR (1989). Immune complex and complement-mediated leukocyte recruitment in bullous pemphigoid. Immunol Ser 46:509-525.
49. Gammon WG, Merritt CC, Lewis DM, Sams WM Jr, Wheeler CE Jr, Carlo JR (1982). Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid. J Invest Dermatol 78:52-57.
50. Gammon WG, Yancey KB, Mangum KL, Hendrix JD, Hammer CH (1989). Generation of C5-dependent bioactivity by tissue-bound anti-BMZ autoantibodies. J Invest Dermatol 93:195-200.
51. Gil SG, Brown TA, Ryan MC, Carter WG (1994). Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation. J Invest Dermatol 103:31S-38S.
52. Giudice GJ, Emery DJ, Diaz LA (1992). Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243-250.
53. Goodwin L, Hill JE, Raynor K, Raszi L, Mana M, Crowin P (1990). Desmoglein shows extensive homology to the cadherin family of cell adhesion molecules. Biochem Biophys Res Commun 173:1224-1230.
54. Green KJ, Jones JCR (1996). Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 10:871-881.
55. Hadi SM, Barnetson RS, Gawkrodger DJ, Saxena U, Bird P, Merrett TG (1988). Clinical, histological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica 176:6-17.
56. Haftek M, Zone JJ, Taylor TB, Kowalewski C, Chorzelski TP, Schmitt D (1994). Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera. J Invest Dermatol 103:656-659.
57. Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH (1983). Anti-cell surface autoantibodies stimulate plasminogen activator activity of human epidermal cells. J Exp Med 157:259-272.
58. Hashimoto T, Ishiko A, Shimizu H, Tanaka T, Dodd HJ, Bhogal BS, et al. (1996). A case of linear IgA bullous dermatosis with IgA anti-type VII collagen. Br J Dermatol 134:336-339.
59. Helm TN, Camisa C, Valenzuela R, Allen CM (1993). Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia. Oral Surg Oral Med Oral Pathol 75:209-213.
60. Herrmann K, Lohrisch I, Bohme HJ, Haustein UF (1978). Detection of antibodies after immune complex splitting in serum of patients with bullous pemphigoid and systemic lupus erythematosus. Br J Dermatol 99:635-640.
61. Holubar K, Wolff K, Konrad K, Beutner EH (1975). Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. J Invest Dermatol 64:220-227.
62. Hopkinson SB, Riddelle KS, Jones JCR (1992). Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol 99:264-270.
63. Hopkinson SB, Baker SE, Jones JCR (1995). Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): Identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha6 integrin. J Cell Biol 130:117-125.
64. Ishida-Yamamoto A, McGrath JA, Chapman SJ, Leigh IM, Lane EB, Eady RA (1991). Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol 97:959-968.
65. Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T (1993). Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 91:1608-1615.
66. Ishiko A, Shimizu H, Masunaga T, Hashimoto T, Dmochowski M, Wojnarowska F, et al. (1996). 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane. J Invest Dermatol 106:739-743.
67. Iwatsuki K, Harada H, Yokote R, Kaneko F (1995). Differences in the expression of pemphigus antigens during epidermal differentiation. Br J Dermatol 133:209-216.
68. Joly P, Thomine E, Gilbert D, Verdier S, Delpech A, Prost C, et al. (1994). Overlapping distribution of autoanti-body specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 103:65-72.
69. Jones JCR, Arnn J, Staehelin LA, Goldman RD (1984). Human autoantibodies against desmosomes: possible causative factors in pemphigus. Proc Natl Acad Sci USA 81:2781-2785.
70. Jones JCR, Yokoo KM, Goldman RD (1986). Further analysis of pemphigus autoantibodies and their use in studies of the heterogeneity, structure, and function of desmosomes. J Cell Biol 102:1109-1117.
71. Jones J, Downer CS, Speight PM (1995a). Changes in the expression of integrins and basement membrane proins in benign mucous membrane pemphigoid. Oral Diseases 1(3):159-165.
72. Jones JC, Hunt SW 3rd, Prisayamh PS, Briggaman RA, Gammon WR (1995b). Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol 104:231-235.
73. Jonkman MF, De Jong MC, Heeres K, Steijlen PM, Owaribe K, Kuster W, et al. (1996). Generalized atrophic benign epidermolysis bullosa. Either 180-kD bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol 132:145-150.
74. Keene DR, Sakai LY, Lunstrum GP, Morris NP, Burgeson RE (1987). Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 104:611-621.
75. Kelly SE, Wojnarowska F (1988). The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 118:31-40.
76. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB (1995). Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 105:543-548.
77. Kitajima Y, Hirako Y, Owaribe K, Yaoita H (1994). A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti-180-kD BPA antibody is an initiator. Dermatology 189(Suppl 1):46-49.
78. Korman NJ (1995). In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid. J Invest Dermatol 105:824-830.
79. Kurpakus MA, Jones JCR (1991). A novel hemidesmosomal plaque component: Tissue distribution and incorporation into assembling hemidesmosomes in an in vitro model. Exp Cell Res 194:139-146.
80. Labib RS, Rock B, Martins CR, Diaz LA (1990). Pemphigus foliaceus antigen: characterization of an immunoreactive tryptic fragment from BALB/c mouse epidermis recognized by all patients' sera and major autoantibody subclasses. Clin Immunol Immunopathol 57:317-329.
81. Lapiere J-C, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM, et al. (1993). Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 92:1831-1839.
82. Lever WF (1979). Pemphigus and pemphigoid. Am Acad Dermatol 1:2-31.
83. Li K, Giudice GJ, Tamai K, Do HC, Sawamura D, Diaz LA, et al. (1992). Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly nserved collagenous protein of the cutaneous basement membrane zone. J Invest Dermatol 99:258-263.
84. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, et al. (1993). A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480-2488.
85. Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL, et al. (1995). The role of complement in experimental bullous pemphigoid. J Clin Invest 95:1539-1544.
86. Lotti T, Bonan P, Cannarozzo G, Panconesi E (1988). In vivo studies on the involvement of urokinase in pemphigus acantholysis. J Invest Dermatol 91:372-373.
87. Lunstrum GP, Sakai LY, Keene DR, Morris NP, Burgeson RE (1986). Large complex globular domains of type VII procollagen contribute to the structure of anchoring fibrils. J Biol Chem 261:9042-9048.
88. Marinkovich MP, Taylor AF, Keene DR, Burgeson RE, Zone JJ (1996). LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDA anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 106:734-738.
89. Martins CR, Labib RS, Rivitti EA, Diaz LA (1990). A soluble and immunoreactive fragment of pemphigus foliaceus antigen released by trypsinization of viable human epidermis. J Invest Dermatol 95:208-212.
90. Martins CR, Squiquera HL, Diaz LA (1993). Pemphigus vulgaris and pemphigus foliaceus. In: Bullous diseases. Provost TT, Weston WL, editors. St. Louis: Mosby Year Book, Inc., pp. 17-61.
91. McGrath JA, Pulkkinen L, Christiano AM, Leigh IM, Eady RA, Uitto J (1995). Altered laminin-5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 104:467-474.
92. McGrath JA, Darling T, Gatalica B, Pohla-Gubo G, Hintner H, Christiano AM, et al. (1996). A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 106:771-774.
93. Mehregan DR, Oursler JR, Leiferman KM, Muller SA, Anhalt GJ, Peters MS (1993). Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia. J Cutan Pathol 20:203-210.
94. Memar OM, Rajaraman S, Thotakura R, Tyring SK, Fan J-L, Seetharamaiah GS, et al. (1996). Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol 1062:261-268.
95. Morioka S, Lazarus GS, Jensen PJ (1987). Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. J Invest Dermatol 89:474-477.
96. Mueller S, Klaus-Kovtun V, Stanley JR (1989). A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 92:33-38.
97. Mutasim DF, Morrison LH, Takahashi Y, Labib RS, Skouge J, Diaz LA, et al. (1988). Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol 92:225-230.
98. Naito K, Morioka S, Ikeda S, Ogawa H (1984). Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells. J Invest Dermatol 82:227-230.
99. Nieboer C, Boorsma DM, Woerdeman MJ (1982). Immunoelectron microscopic findings in cicatricial pemphigoid: their significance in relation to epidermolysis bullosa acquisita. Br J Dermatol 106:419-421.
100. Niimi Y, Zhu X-J, Bystryn J-C (1992). Identification of cicatricial pemphigoid antigens. Arch Dermatol 128:54-57.
101. Onodera Y, Hashimoto SH, Ebihara IA, Tanaka M, Nishikawa T (1994). Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. J Invest Dermatol 102:686-690.
102. Osada K, Seishima M, Kitajima Y (1997). Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 108:482-487.
103. Oursier JR, Labib RS, Ariss-Abdo L, Burke T, O'Keefe EJ, Anhalt GJ (1992). Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 89:1775-1782.
104. Owaribe K, Nishizawa Y, Franke WW (1991). Isolation and characterization of hemidesmosomes from bovine corneal epithelial cells. Exp Cell Res 192(2):622-630.
105. Pas HH, de Jong MCJM, Jonkman MF, Heeres K, SlijperPal IJ, van der Meer JB (1995). Bullous pemphigoid: serum antibody titre and antigen specificity. Exp Dermatol 4:372-376.
106. Pas HH, Kloosterhuis GJ, Heeres K, van der Meer JB, Jonkman MF (1997). Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol 108:423-429.
107. Robledo MA, Kim S-C, Korman NJ, Stanley JR, Labib RS, Futamura S, et al. (1990). Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. J Invest Dermatol 94:793-797.
108. Rock B, Martins CR, Theofilopoulos AN, Balderas RS, Anhalt GJ, Labib RS, et al. (1989). The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 320:1463-1469.
109. Rock B, Labib RS, Diaz LA (1990). Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disse in neonatal Balb/c mice. J Clin Invest 85:296-299.
110. Rousselle P, Lunstrum GP, Keene DR, Burgeson RE (1991). Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 114:567-576.
111. Sakai LY, Keene DR, Engvall E (1986). Fibrillin, a new glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499-2509.
112. Sams WM Jr, Gammon WR (1980). Mechanism of lesion production in pemphigus and pemphigoid. Am Acad Dermatol 6:431-449.
113. Sarret Y, Hall R, Cobo M, Thivolet J, Patton DL, Woodley DT (1991). Screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies. J Am Acad Dermatol 24:952-958.
114. Schiltz JR, Michel B (1976). Production of epidermal acantholysis in human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 67:254-260.
115. Schroeder HE (1981). Differentiation of human oral stratified epithelia. Basel: S. Karger.
116. Schroeder HE (1986). The periodontium. Berlin: Springer-Verlag.
117. Shimizu H, McDonald JN, Gunner DB, Black MM, Bhogal B, Leigh IM, et al (1990). Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane. Br J Dermatol 122:577-585.
118. Shimizu H, Masunaga T, Ishiko A, Kikuchi A, Hashimoto T, Nishikawa T (1995). Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding pattern to extracellular regions of desmosomes in different layers of human epidermis. J Invest Dermatol 105:153-159.
119. Shklar G, McCarthy PL (1971). Oral lesions of mucous membrane pemphigoid. A study of 85 cases. Arch Otolaryngol Head Neck Surg 93:354-364.
120. Silos SA, Tamai K, Li K, Kivirikko S, Kouba D, Christiano AM, et al. (1996). Cloning of the gene for human pemphigus vulgaris antigen (desmoglein 3), a desmosomal cadherin. J Biol Chem 271:17504-17511.
121. Sonnenberg A, Calafat J, Janssen H, Daams H, van der Raaij-Helmer LMH, Falcioni R, et al. (1991). Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 113:907-917.
122. Stanley JR (1989). Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 83:1443-1448.
123. Stanley JR (1995). What is the epidermal intercellular cement and why is it important? J Dermatol 22:836-838.
124. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI (1981). Characterization of bullous pemphigoid antigen: a unique basement membrane proin of stratified squamous epithelia. Cell 24:897-903.
125. Stanley JR, Koulu L, Thivolet C (1984a). Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest 74:313-320.
126. Stanley JR, Woodley DT, Katz SI (1984b). Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol 82:108-111.
127. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop R (1988). Isolation of a complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 82:1864-1870.
128. Stephens RW, Bokman AM, Myöhänen HT, Reisberg T, Tapiovaara H, Pedersen N, et al. (1992). Heparin binding to the urokinase kringle domain. Biochemistry 31:7572-7579.
129. Stepp MA, Spurr-Michaud S, Tisdale A, Elwell J, Gibson JK (1990). Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci USA 87:8970-8974.
130. Tamai K, Sawamura D, Choi Do HY, Li K, Uitto J (1994). Molecular biology of the 230-kD bullous pemphigoid antigen. Dermatology 189(Suppl 1):27-33.
131. Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T (1996). Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol 21:23-27.
132. Tanaka T, Parry DAD, Klaus-Kovtun V, Steinert PM, Stanley JR (1991). Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem 266:12555-12559.
133. Tanaka T, Takahashi K, Furukawa F, Imamura S (1992). Molecular cloning and characterization of type VII collagen cDNA. Biochem Biophys Res Commun 183:958-963.
134. Tanaka T, Furukawa F, Imamura S (1994). Epitope mapping for epidermolysis bullosa acquisita autoantibodies by molecularly cloned cDNA for type VII collagen. J Invest Dermatol 102:706-709.
135. Tang HY, Chaffotte AF, Thacher SM (1996). Structural analysis of the predicted coiled-coil rod domain of the cytoplasmic bullous pemphigoid antigen (BPAG1). Empirical localization of the N-terminal globular domain-rod boundary. J Biol Chem 271:9716-9722.
136. , Christiano AM (1992). Molecular genetics of the cutaneous basement membrane zone. J Clin Invest 90:687-692.
137. Vassalli J-D, Baccino D, Belin D (1985). A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100:86-92.
138. Vassar R, Coulombe PA, Degenstein L, Albers K, Fuchs E (1991). Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 64:356-380.
139. Vincent SD, Lilly GE, Baker KA (1993). Clinical, historic, and therapeutic features of cicatricial pemphigoid. Oral Surg Oral Med Oral Pathol 76:453-459.
140. Wheeler GN, Parker AE, Thomas CL, Ataliotis P Poynter D, Arnemann J, et al. (1991). Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA 88:4796-4800.
141. Williams DM (1993). Non-infectious diseases of the oral soft tissue: a new approach. Adv Dent Res 7:213-219.
142. Wood GW, Beutner EH, Chorzelski TP (1972). Studies in immunodermatology. II. Production of pemphigus-like lesions by intradermal injection of monkeys with Brazilian pemphigus foliaceus sera, Int Arch Allergy 42:556-564.
143. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AQ, Queen LL, Gammon WG (1984). Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 310:1007-1013.
144. Woodley DT, O'Keefe EJ, Reese Ml, Mechanic GL, Briggaman RA, Gammon WR (1986). Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol 86:668-672.
145. Yancey KB, Kirtschig G, Yee C, Lazarova Z (1995). Studies of patients with anti-epiligrin cicatricial pemphigoid. J Dermatol 22:829-835.
146. Yaoita H, Briggaman RA, Lawley TJ, Provost TT, Katz SI (1981). Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 76:288-292.
147. Zone J (1993). Dermatitis herpetiformis, linear IgA bullous disease, and chronic bullous disease of childhood. In: Bullous diseases. Provost TT, Weston WL, editors. St. Louis: Mosby Year Book, Inc., pp. 157-212.